These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10981913)

  • 21. 759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain.
    Basile VS; Masellis M; De Luca V; Meltzer HY; Kennedy JL
    Lancet; 2002 Nov; 360(9347):1790-1. PubMed ID: 12480467
    [No Abstract]   [Full Text] [Related]  

  • 22. Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine.
    Malhotra AK; Goldman D; Ozaki N; Breier A; Buchanan R; Pickar D
    Am J Psychiatry; 1996 Aug; 153(8):1092-4. PubMed ID: 8678181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between clozapine response and allelic variation in 5-HT2A receptor gene.
    Arranz M; Collier D; Sodhi M; Ball D; Roberts G; Price J; Sham P; Kerwin R
    Lancet; 1995 Jul; 346(8970):281-2. PubMed ID: 7630250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variants of the serotonin system and weight change during clozapine treatment.
    Hong CJ; Lin CH; Yu YW; Yang KH; Tsai SJ
    Pharmacogenetics; 2001 Apr; 11(3):265-8. PubMed ID: 11337942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel mutations in 5-HT3A and 5-HT3B receptor genes not associated with clozapine response.
    Gutiérrez B; Arranz MJ; Huezo-Diaz P; Dempster D; Matthiasson P; Travis M; Munro J; Osborne S; Kerwin RW
    Schizophr Res; 2002 Nov; 58(1):93-7. PubMed ID: 12363396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetics of novel therapeutic targets in schizophrenia.
    Kerwin R; Owen M
    Br J Psychiatry Suppl; 1999; (38):1-4. PubMed ID: 10884894
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacogenetics in schizophrenia: a review of clozapine studies.
    Kohlrausch FB
    Braz J Psychiatry; 2013; 35(3):305-17. PubMed ID: 24142094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response.
    Souza RP; Romano-Silva MA; Lieberman JA; Meltzer HY; MacNeil LT; Culotti JG; Kennedy JL; Wong AH
    J Psychiatr Res; 2010 Aug; 44(11):700-6. PubMed ID: 20116071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic predictors of therapeutic response to clozapine: current status of research.
    Mancama D; Arranz MJ; Kerwin RW
    CNS Drugs; 2002; 16(5):317-24. PubMed ID: 11994021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response.
    Souza RP; Meltzer HY; Lieberman JA; Le Foll B; Kennedy JL
    Hum Psychopharmacol; 2010 Nov; 25(7-8):582-5. PubMed ID: 20860064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine D4 receptor gene exon III polymorphism and interindividual variation in response to clozapine.
    Zhao AL; Zhao JP; Zhang YH; Xue ZM; Chen JD; Chen XG
    Int J Neurosci; 2005 Nov; 115(11):1539-47. PubMed ID: 16223700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of association between the T-->C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia.
    Masellis M; Basile VS; Meltzer HY; Lieberman JA; Sevy S; Goldman DA; Hamblin MW; Macciardi FM; Kennedy JL
    Schizophr Res; 2001 Jan; 47(1):49-58. PubMed ID: 11163544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementation of pharmacogenetics in a clozapine treatment resistant patient: a case report.
    Sangüesa E; Cirujeda C; Concha J; Padilla PP; Ribate MP; García CB
    Pharmacogenomics; 2019 Aug; 20(12):871-877. PubMed ID: 31453772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of dopamine receptor D1 rs4532 polymorphism and susceptibility to antipsychotic treatment response.
    de Matos LP; Santana CV; Souza RP
    Psychiatry Res; 2015 Sep; 229(1-2):586-8. PubMed ID: 26213377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
    Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
    J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenomics and schizophrenia: clinical implications.
    Malhotra AK
    Pharmacogenomics J; 2001; 1(2):109-14. PubMed ID: 11911437
    [No Abstract]   [Full Text] [Related]  

  • 37. Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes.
    Souza RP; de Luca V; Meltzer HY; Lieberman JA; Kennedy JL
    Int J Neuropsychopharmacol; 2010 Jul; 13(6):793-8. PubMed ID: 20196918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of serotonin in forensic psychiatry.
    Buckley P; Gardner G; Lee S; Torigoe F
    Bull Am Acad Psychiatry Law; 1996; 24(3):419-22. PubMed ID: 8889140
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update.
    Sriretnakumar V; Huang E; Müller DJ
    Expert Opin Drug Metab Toxicol; 2015; 11(11):1709-31. PubMed ID: 26364648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response.
    Huang E; Maciukiewicz M; Zai CC; Tiwari AK; Li J; Potkin SG; Lieberman JA; Meltzer HY; Müller DJ; Kennedy JL
    Pharmacogenomics; 2016; 17(2):103-9. PubMed ID: 26666695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.